Security Snapshot

AYTU BIOPHARMA, INC - Common Stock (AYTU) Institutional Ownership

CUSIP: 054754858

13F Institutional Holders and Ownership History from Q1 2023 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

36

Shares (Excl. Options)

3,835,947

Price

$2.15

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
AYTU on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
3,835,947
Latest holder snapshot 5 signals
Total 13F value
$8,248,348
Portfolio coverage rank
0%
Share change
-67,225
Value change
-$146,433
Number of holders
36
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
10,940,802
SEC-reported price per share
$2.38
Insider filing price
$2.38
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AYTU - AYTU BIOPHARMA, INC - Common Stock is tracked under CUSIP 054754858.
  • 36 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 34 to 36 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $10,653,381 to $8,248,348.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 36 institutions filings for Q2 2026.

Open SEC evidence

Security key

054754858

Latest holder period

Q2 2026

13F holders

36

13D/G owners

3

CIK / CUSIP context first

Open Q2 2026 holders AYTU full holder history AYTU BIOPHARMA, INC SEC filings AYTU BIOPHARMA, INC company facts AYTU BIOPHARMA, INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
AYTU
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 14% $1,423,724 1,086,812 Nantahala Capital Management, LLC 06 Jun 2025
Stonepine Capital Management, LLC 9.9% $1,975,217 906,063 Stonepine Capital Management, LLC 30 Jun 2025
LYTTON LAURENCE W 5% -50% $1,228,378 -$1,182,161 545,946 -49% LYTTON LAURENCE W 30 Jun 2026

As of 30 Jun 2026, 36 institutional investors reported holding 3,835,947 shares of AYTU BIOPHARMA, INC - Common Stock (AYTU). This represents 35% of the company’s total 10,940,802 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
35%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 9.9% 1,086,812 0% 0.14% $2,336,646
Stonepine Capital Management, LLC 8.3% 912,921 +15% 1.5% $1,962,780
AWM Investment Company, Inc. 5.7% 619,574 0% 0.12% $1,332,084
VANGUARD CAPITAL MANAGEMENT LLC 2.4% 261,146 0% 0% $561,464
CROWN ADVISORS MANAGEMENT, INC. 1.8% 200,000 +38% 0.24% $430,000
DIADEMA PARTNERS LP 1.4% 148,546 -58% 0.12% $319,374
TWO SIGMA INVESTMENTS, LP 0.96% 105,326 -14% 0% $226,451
RENAISSANCE TECHNOLOGIES LLC 0.96% 104,823 +12% 0% $225,369
GEODE CAPITAL MANAGEMENT, LLC 0.86% 93,647 +1.1% 0% $201,371
CITADEL ADVISORS LLC 0.45% 49,414 +34% 0% $106,240
VANGUARD FIDUCIARY TRUST CO 0.43% 47,048 0% 0% $101,153
DIMENSIONAL FUND ADVISORS LP 0.41% 45,326 +4% 0% $97,451
Persistent Asset Partners Ltd 0.35% 37,984 -59% 0.03% $81,666
NORTHERN TRUST CORP 0.26% 27,925 +46% 0% $60,039
BELLEVUE ASSET MANAGEMENT, LLC 0.23% 25,013 0% 0.02% $53,777
BlackRock, Inc. 0.21% 22,793 0% 0% $49,005
XTX Topco Ltd 0.2% 21,416 -0.77% 0% $46,044
ACADIAN ASSET MANAGEMENT LLC 0.09% 10,237 0% 0% $22,000
Daytona Street Capital LLC 0.09% 10,000 0% 0.02% $22,350
UBS Group AG 0.02% 2,377 +43% 0% $5,110
Tower Research Capital LLC (TRC) 0.02% 2,232 +43% 0% $4,799
OSAIC HOLDINGS, INC. 0% 462 0% 0% $991
ROYAL BANK OF CANADA 0% 378 0% $1,000
JPMORGAN CHASE & CO 0% 154 0% 0% $337
WELLS FARGO & COMPANY/MN 0% 127 0% 0% $273

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
14
Latest
Q2 2026
Rows shown
1-14 of 14
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 3,835,947 $8,248,348 -$146,433 $2.15 36
2026 Q1 3,903,172 $10,653,381 +$348,828 $2.73 34
2025 Q4 3,771,496 $9,805,147 +$483,628 $2.60 37
2025 Q3 3,580,253 $6,730,606 +$120,541 $1.88 31
2025 Q2 3,416,181 $7,446,105 +$3,456,447 $2.18 30
2025 Q1 1,876,606 $2,489,917 +$8,023 $1.20 29
2024 Q4 1,880,741 $3,193,340 -$294,695 $1.70 28
2024 Q3 2,048,299 $4,813,170 -$27,368 $2.35 23
2024 Q2 2,053,775 $5,994,953 +$752,481 $2.92 26
2024 Q1 1,795,464 $5,457,735 +$79,751 $3.04 26
2023 Q4 1,769,256 $5,024,294 +$125,688 $2.84 21
2023 Q3 1,724,718 $4,655,967 +$78,103 $2.70 20
2023 Q2 1,704,120 $2,726,370 +$1,773,284 $1.60 19
2023 Q1 540,753 $1,211,630 +$1,211,205 $2.24 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .